CanSino Biologics Inc. (06185) Publishes February 2026 Monthly Return

Bulletin Express

Yesterday

Stock Code: 06185 Stock Name: CanSino Biologics Inc.

In February 2026, CanSino Biologics Inc. reported that its total authorized share capital remained at RMB 247.04 million, including approximately 132.67 million H shares and 114.37 million A shares (both rounding to two decimals). There were no changes to the number of issued shares or treasury shares across H shares and A shares during the month. The H-share public float requirement was confirmed to be in compliance.

Under the 2025 Core Management H Share Option Scheme, 860,000 H share options remained outstanding throughout February 2026, with no new shares issued during the period. For the 2025 Restricted A Share Incentive Scheme, 2.05 million restricted A shares (rounded to two decimals) remained available for issuance, with no shares issued in February 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1133254764"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1133254764\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1133254764?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-02 16:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1133254764","market":"hk","top_or_hot":-1,"title":"CanSino Biologics Inc. (06185) Publishes February 2026 Monthly Return","media":"Bulletin Express","content":"<p>Stock Code: 06185  \nStock Name: CanSino Biologics Inc.</p>\n<p>In February 2026, CanSino Biologics Inc. reported that its total authorized share capital remained at RMB 247.04 million, including approximately 132.67 million H shares and 114.37 million A shares (both rounding to two decimals). There were no changes to the number of issued shares or treasury shares across H shares and A shares during the month. The H-share public float requirement was confirmed to be in compliance.</p>\n<p>Under the 2025 Core Management H Share Option Scheme, 860,000 H share options remained outstanding throughout February 2026, with no new shares issued during the period. For the 2025 Restricted A Share Incentive Scheme, 2.05 million restricted A shares (rounded to two decimals) remained available for issuance, with no shares issued in February 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CanSino Biologics Inc. (06185) Publishes February 2026 Monthly Return</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCanSino Biologics Inc. (06185) Publishes February 2026 Monthly Return\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-02 16:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Stock Code: 06185  \nStock Name: CanSino Biologics Inc.</p>\n<p>In February 2026, CanSino Biologics Inc. reported that its total authorized share capital remained at RMB 247.04 million, including approximately 132.67 million H shares and 114.37 million A shares (both rounding to two decimals). There were no changes to the number of issued shares or treasury shares across H shares and A shares during the month. The H-share public float requirement was confirmed to be in compliance.</p>\n<p>Under the 2025 Core Management H Share Option Scheme, 860,000 H share options remained outstanding throughout February 2026, with no new shares issued during the period. For the 2025 Restricted A Share Incentive Scheme, 2.05 million restricted A shares (rounded to two decimals) remained available for issuance, with no shares issued in February 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06185","symbol_name":"康希诺生物","start_time":0,"source_url":"","article_id":"1133254764","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1133254764","pubTimestamp":1772441299,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Stock Code: 06185   Stock Name: CanSino Biologics Inc. In February 2026, CanSino Biologics Inc. reported that its total authorized share capital remained at RMB 247.04 million, including...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06185":"康希诺生物"},"translate_title":"康希诺生物股份公司(06185)发表2026年2月月报表","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06185":1},"content_text":"Stock Code: 06185  \nStock Name: CanSino Biologics Inc.\nIn February 2026, CanSino Biologics Inc. reported that its total authorized share capital remained at RMB 247.04 million, including approximately 132.67 million H shares and 114.37 million A shares (both rounding to two decimals). There were no changes to the number of issued shares or treasury shares across H shares and A shares during the month. The H-share public float requirement was confirmed to be in compliance.\nUnder the 2025 Core Management H Share Option Scheme, 860,000 H share options remained outstanding throughout February 2026, with no new shares issued during the period. For the 2025 Restricted A Share Incentive Scheme, 2.05 million restricted A shares (rounded to two decimals) remained available for issuance, with no shares issued in February 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}